In this study, we investigated the prevalence and prognostic value of somatic EZH2 mutations in 714 patients with de novo AML by PCR amplification of the entire coding region of EZH2 followed by direct bidirectional DNA sequencing. Here, EZH2 is linked to acute myeloid leukemia.